1

CURRICULUM VITAE

MAUREEN PATRICIA FLATTERY, RN, MS, ANP

EDUCATION

Master of Science

Adult Nurse Practitioner Program

VirginiaCommonwealthUniversity, Richmond, Virginia, 2000

Bachelor of Science in Nursing

Magna Cum Laude

NiagaraUniversity, Niagara University, New York, 1980

PROFESSIONAL EXPERIENCE

Adult Nurse PractitionerNovember 2002- Present

Heart Failure/Transplant Program

VirginiaCommonwealthUniversity Health System

Richmond, Virginia23298

Clinical CoordinatorNovember 1992- November 2002

Heart Failure/Transplant Program

MedicalCollege of Virginia

Richmond, Virginia23298

Staff NurseOctober 1984- November 1992

Cardiac Surgery ICU

MedicalCollege of Virginia

Richmond, Virginia 23298

LICENSURE

RNCommonwealth of Virginia #94565

State of New York #329087-1 (inactive)

NPCommonwealth of Virginia #0024165357

Prescriptive Authority- VA#0017137703

PROFESSIONAL ORGANIZATIONS

Member, International Society of Heart and Lung Transplantation

  • Member, Steering Committee of the Nursing and Social Science Council (2002-2004)

Member, Virginia Council of Nurse Practitioners

  • President-elect, Richmond Region, 2008-09
  • President, Richmond Region, 2009-10
  • Past President, Richmond Region, 2010-11
  • Chair, State Education Committee, 2010-14

Member, American Association of Heart Failure Nurses

  • Member, Education Committee, 2006-08
  • Member, Publications Committee, 2008-12
  • Committee chair, 2010-12
  • Editor, Quarterly newsletter, 2008-10

Member, Heart Failure Society of America (1997-2010)

  • Member, Program Committee, 2008 & 2009 Annual Meetings

RELATED EXPERIENCES

  • Presenter, “Introduction to Hemodynamic Monitoring” August 1982, CentralSuffolkHospital, Riverhead, New York.
  • One of three contributors to the MCV-CSICU Pediatric Manual
  • Lecturer, Pediatric Workshops on congenital defects, neurological differences in children and bedside set-up, 1986-1991, Medical College of Virginia, Richmond, Virginia.
  • Developed Patient Teaching Protocol “Discharge Teaching for Parents of the Infant with Hypoplastic Left Heart Syndrome”.
  • Presenter, “Staff of the Year Awards” for above protocol, 1988.
  • Lecturer, “Complications of MI” in the Cardiopulmonary Core Curriculum September 1986, April 1987, Medical College of Virginia, Richmond, Virginia.
  • Lecturer, “Hypoplastic Left Heart Syndrome: Surgical Intervention and Care” at the AACN Neonatal and Pediatric Critical Care Conference, March 4, 1990, Richmond, Virginia.
  • Lecturer, “Pediatric Heart Transplantation” at the Cardiovascular Transplant Workshop, November 1990, Medical College of Virginia, Richmond, Virginia.
  • Lecturer, “Pediatric Heart Transplantation” at the Innovations in Cardiovascular Nursing Conference, June 21, 1991, Richmond, Virginia.
  • Lecturer, “Pediatric Heart Transplantation” at the Pediatric Critical Care Core, April 7, 1993, Medical College of Virginia, Richmond, Virginia.
  • Lecturer, “Heart Transplantation” at the Transplant and Immunology Core, 1993-1997, Medical College of Virginia, Richmond, Virginia.
  • Lecturer, “Management of Patients Receiving a Lung Transplant” at the 4th Annual Critical Care Update, November 16, 1995, Richmond, Virginia.
  • Lecturer, “Cardiac Disease: When Enough is Enough” at the GRAC-AACN Annual Update, March 16, 1999, Richmond, Virginia.
  • Abstract reviewer: International Society for Heart and Lung Transplantation: 2001.
  • Chapter reviewer, 2002
  • Lecturer, “Health Promoting Behaviors in Long Term Cardiac Transplant Recipients” at Heart Matters, November 22, 2002, Richmond, Virginia.
  • Presenter, “Effects of Attending a Community-Based Weight Management Program on Weight Loss, Lipid Profile, and Blood Pressure in Long-term Cardiac Transplant Recipients”, ITNS Chesapeake Chapter Educational Forum, June 14, 2003.
  • Presenter, “Living with Pulmonary Hypertension”, ITNS Chesapeake Chapter Educational Forum, October 25, 2003.
  • Lecturer, “Congestive Heart Failure”, March 16 & 17, 2004 (sponsored by Pfizer).
  • Lecturer, “Congestive Heart Failure”, June 23, 2004 (sponsored by Pfizer).
  • Lecturer, “Heart Failure: Impact on Lifestyle”, October 7, 2004 (sponsored by Pfizer).
  • Lecturer, “Heart Failure: Role of the Nurse Practitioner”, December 3, 2004 (sponsored by Medtronic).
  • Lecturer, “Heart Failure: Impact on Lifestyle”, March 31, 2005 (sponsored by Medtronic).
  • Editorial board member, Progress in Cardiovascular Nursing, 2005-2009.
  • Member, Medtronic Southeastern Nurse Practitioner Advisory Board, August 2004- 2006.
  • Lecturer, “Heart Failure Management in 2005: a Clinical Update”, for the Virginia Council of Nurse Practitioners, August 18, 2005 (sponsored by Medtronic).
  • Lecturer, “Clinical Application of Genetic Testing in Heart Transplant Recipients” (sponsored by XDx) Six teleconferences, 2006.
  • Lecturer, “Advanced Case Studies in Heart and Lung Transplantation”, for Advances in Transplantation, WashingtonDC, October 3, 2006.
  • Lecturer, “Incorporating New Technology into Practice”, for Pittsburgh, PA chapter of ITNS, (sponsored by XDx) January 23, 2007.
  • Co-presenter, “From Observation to Research in Nursing and Social Sciences: Acting on Your Ideas”, for ISHLT 27th Annual Meeting and Scientific Sessions, San Francisco, CA, April 27, 2007.
  • Lecturer, “Incorporating New Technology into Practice”, for Durham/Chapel Hill, NC chapter of ITNS, (sponsored by XDx) February 12, 2008.
  • Abstract reviewer, HFSA 12th Scientific Session, 2008
  • Presenter, Care of the Outpatient LVAD Patient,” HFSA 12th Scientific Session, Toronto, Canada, September 23, 2008.
  • Abstract reviewer, HFSA 13th Scientific Session, 2009.
  • Reviewer, Journal of Cardiovascular Nursing. 2009-present.
  • Reviewer, Heart Failure Nursing Certification: Core Curriculum Review.

RESEARCH EXPERIENCE

  • Multi-institutional Study: A Longitudinal Study of Perceived Stressors and Coping Strategies among Cardiac Transplant Patients during the Organ Waiting Period. (co-investigator) 1993-1996.
  • Multi-institutional Study: Stress and Coping in Parents of Children Awaiting Cardiac Transplantation. (co-investigator) 1993-1995.
  • Multi-institutional Study: Pediatric Heart Transplant Study Group. (institutional data coordinator) 1993-1996.
  • Dynamic Cardiomyoplasty Clinical Trial. (study coordinator at primary US site) 1994-1996.
  • Multi-institutional Study: BEST (Beta-blocker Evaluation of Survival Trial) study coordinator 1995-2000.
  • Multi-institutional Study: Toborinone vs. Milrinone in Patients with CHF (study coordinator) 1996-1998.
  • Multi-institutional study: Cardiac Transplant Research Database (institutional data coordinator) 1999-2010.
  • Multi-institutional study: The Prefer Study (study coordinator) 2000-01.
  • Health Promoting Lifestyle in Long-term Cardiac Transplant Recipients (co-investigator) 1999. Funded by a grant from the Nursing Council of the International Society of Heart and Lung Transplantation.
  • Effects of Attending a Community-Based Weight Management Program on Weight Loss, Lipid Profile, and Blood Pressure in Long-term Cardiac Transplant Recipients: A Feasibility Study. (co-investigator) 1999-2002.
  • Multi-institutional Study: Mechanical Circulatory Support Database (institutional data coordinator). 2001-2006.
  • Multi-institutional study: A-HEFT Study (study coordinator) 2002-2004.
  • Living with Pulmonary Artery Hypertension 2002-2003 (co-investigator). Funded by a grant from the Gamma Omega chapter of Sigma Theta Tau International.
  • Multi-institutional study: WARCEF Study (co-study coordinator) 2003-2009.
  • Multi-institutional study: A Phase 2, dose escalating evaluation of carperitide in subjects with CHF (study coordinator) 2003-2006.
  • Multi-institutional study: Follow-up Serial Infusions of Natrecor® (FUSION II) (study coordinator) 2004- 2005.
  • Caregiver Burden and the Left Ventricular Assist Device (co-investigator) Funded by a grant from the Gamma Omega Chapter of Sigma Theta Tau International. 2005-2007.
  • Multi-institutional study: Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) (Study Coordinator) 2006-2012.
  • Symptom Clusters in Patients with Heart Failure. (co-investigator). 2009-present.
  • Living with the Total Artificial Heart (2010-2012). Co-investigator.
  • Building Research Initiative Group: Chronic Illness Management and Adherence in Transplantation Study. (2013-2014). Site investigator.
  • Outcomes Allomap Registry. (2013-present). Sub-investigator

GRANTS AND AWARDS

  • Recipient 2002 Research Award of the Gamma Omega Chapter of Sigma Theta Tau International for the proposal, “Living with Pulmonary Artery Hypertension”. (co-investigator).
  • Recipient 2005 Research Award of the Gamma Omega Chapter of Sigma Theta Tau International for the proposal, “Caregiver Burden and the Left Ventricular Assist Device: (co-investigator).
  • Recipient 2006 Virginia Council of Nurse Practitioners Educator of the Year Award.
  • Recipient 2006VirginiaCommonwealthUniversity Health System Excellence in Advanced Practice Nursing Award.
  • Recipient 2014 Virginia Council of Nurse Practitioners Founders’ Award.

BOOK CHAPTER

  • Augustine SMFlattery MP (2002) Long-Term Complications of Solid Organ Transplantation, in Transplantation Nursing Secrets,Philadelphia: Hanley and Belrus, Inc.
  • Flattery MP & Dale C. (2007) Solid Organ Transplantation. The Evaluation Process, in Core Curriculum for Transplant Nurses, Philadelphia: Mosby, Inc.
  • Flattery M & Constantino S. (2012) Advanced Heart Failure Therapies, in Heart Failure Nursing Certification: Core Curriculum Review. Mt Laurel, NJ: American Association of Heart Failure Nurses.
  • Flattery M. (2012) Implantable Cardiac Devices Used in Heart Failure Patients, in Heart Failure Nursing Certification: Core Curriculum Review. Mt Laurel, NJ: American Association of Heart Failure Nurses.

ABSTRACTS

  • Ohler L, Augustine S, Cupples S, Nolan M, Kynoch D &Flattery M. (1994) A Longitudinal Study of Perceived Stressors and Coping Strategies Among Cardiac transplant Patients during the Organ Waiting Period. Journal of Heart and Lung Transplantation, 13(2) S49.
  • Suddaby EC, Flattery MP, Mashburn C Luna M. Stress and Coping in Parents of Children Awaiting Cardiac Transplant. (NATCO Annual Meeting, 1996).
  • Salyer JJ, Flattery MPJoyner, PL. (2001) Health Lifestyle and Quality of Life in Long-term Cardiac Transplant Recipients. Journal of Heart and Lung Transplantation, 20(2), 203-4.
  • Kundur, RN, Flattery, MP Hess, ML. (2001) Homocysteine/Coronary Atherosclerosis and Cardiac Transplantation: A Case Control Study. Journal of Heart and Lung Transplantation, 20(2), 196.
  • Higgins RSD, Flattery M, Hanrahan J, Wolfe L, DeAnda A, Kasirajan V. Prospective evaluation of short course thymoglobulin induction immunosuppression in heart transplant recipients. American Transplant Congress, 2001.
  • Salyer JJ, Flattery MP, Maltby MC, Joyner PL & Elswick RK. (2002) Lifestyle & health status differ as a function of time in long-term cardiac transplant recipients. Journal of Heart and Lung Transplantation, 21(1), 110-11.
  • Kimball PM, Higgins RS & Flattery MP. (2002) Weak Immune responder status associated with poorer long-term outcome following heart transplantation. American Transplant Conference, 2002.
  • Higgins R, Naftel DC, Rayburn B, Wagoner L, Oren R, Aaronson K, Miller L, Rodeheffer R & Flattery M. (2003) To induce or not to induce: current assessment of perioperative practices in heart transplantation. Journal of Heart and Lung Transplantation, 22 (1S), S176.
  • Salyer JJ, Flattery MP, Joyner PL & Elswick RK. (2003) A community-based weight management program for cardiac transplant recipients: results of a pilot study. Journal of Heart and Lung Transplantation, 22 (1S), S130.
  • Savage L, Flattery M, Pinson J & Salyer J. (2003) Living with pulmonary artery hypertension. American Journal of Critical Care, 12(3) 274.
  • Salyer J, Flattery MP, Sharp FB, Baker KM, Allen A & Best A. (2006) Psychosocial and biological factors influencing perceptions of health status. Journal of Heart and Lung Transplantation, 25 (2S) S179.
  • Sharp PB, Baker K, Flattery MP & Salyer J. Cardiac allograft vasculopathy and steroid therapy: impact on perceived health status and functional capacity in heart transplant recipients. Poster presentation at the 17th International Nursing Research Congress Focusing on Evidence-Based Practice. Montreal, Quebec, Canada. July 20, 2006.
  • Kimball PM, Mitchell A, Flattery M & Kasirajan V. T cell responses are reduced among heart failure patients on ventricular device support. World Transplant Congress, Boston, MA, July 24, 2006.
  • Flattery MP, Baker K, Haugh KH, Maltby MC & Salyer J. Caregiving for patients requiring left ventricular assist device support. Poster presentation at the American Association of Heart Failure Nurses Annual Meeting. San Diego CA. June 29, 2007.
  • Flattery M,Ohler, Doolin K, Hess M, Cooke R, Harton S & Kasirajan V. (2009) Use of a CardioWest TAH-t for high risk patients reduces complications and improves survival. Journal of Heart and Lung Transplantation, 28 S276-7.
  • White-Williams C, Collier M, Flattery M,Law K, Laxson C, Schlemm A, St. Clair K, Brown RN & Kirklin J.(2009)The impact of non-compliance on survival after heart transplantation: a multi-institutional study.Journal of Heart and Lung Transplantation, 28, S145.
  • Kasirajan V,Flattery M Kimball P. (2010) Positive Flow Crossmatches Associates with Poorer Outcomes. Journal of Heart and Lung Transplantation, 29, S151.
  • Kohli HS, Canada J, Arena RA, Tang DG, Peberdy MA, Harton S, Flattery M, Katlaps GJ, Hess ML, Kasirajan V & Shah KB. (2011) Flat blood pressure response to exercise in patients with the total artificial heart. Journal of Heart and Lung Transplantation.
  • Mankad AK, Flattery M, Tang DG, Clark W, Harton S, Katlaps GJ, Hess ML, Kasirajan V & Shah KB. Persistent anemia in patients supported with the total artificial heart: hemolysis and ineffective erythropoiesis. Annual Scientific Meeting of the Heart Failure Society of America, Boston, MA, Sep. 18-21, 2011.
  • Shah KB, Flattery MP, Sheldon EH, Thacker L, Doolin K, Merinar G, Cooke RH, Hess ML. Surveillance endomyocardial biopsy early after heart transplantation has a low yield for detecting cellular rejection in the modern era. Journal of Heart and Lung Transplantation, 2012; 31: S169.
  • Rennyson SL, Flattery MP, Merinar GA, Tang DG, Katlaps GJ, Cooke RH, Hess ML, Kasirajan V, Shah KB. Normalization of pulmonary vascular resistance after bridging to heart transplantation with the total artificial heart. Journal of Heart and Lung Transplantation, 2012; 31: S263.
  • Savage LS, Flattery MP & Salyer J. Living with a total artificial heart. Journal of Heart and Lung Transplantation, 2012; 31: S90.
  • Shah KB, Flattery MP & Doolin K. Women in a predominantly African American population exhibit lower gene expression scores early after heart transplant. Journal of Heart and Lung Transplantation, 2012; 31: S167.
  • Maltby M, Flattery M, Barclay A, Kasirajan V, Tang D, Hess M, Harton S, Olbrisch ME & Shah K. Pre implant noncompliance does not predict social success in LVAD recipients. Journal of Heart and Lung Transplantation, 2012; 31: S50.
  • Maltby MC, Flattery MP, Burns BA, & Shah KB. Modification of the psychosocial assessment of candidates for transplantation (PACT) improves risk classification and prediction of hospital readmission of MCS patients. Journal of Heart and Lung Transplantation, 2013; 32: S179.
  • Salyer J, Flattery MP & Lyon DE. Effect of symptom clusters on quality of life in patients with heart failure. Journal of Heart and Lung Transplantation, 2013; 32: S126.
  • Tang DG, Reddy GB, Flattery MP, Shah KB & Kasirajan V. Low rate of allosensitization with the Syncardia Total Artificial Heart and the Heartmate II LVAD. Journal of Heart and Lung Transplantation, 2013; 32: S237.
  • Salyer J, Flattery MP & Herr JK. Heart failure symptom clusters and functional status. Journal of Heart and Lung Transplantation, 2014; 33: S125.
  • ChristopherS, Hassanein MT, FlatteryMP, Smallfield MC, Cooke RH & Shah KB. Novel lipoprotein markers remain elevated despite statin therapy after heart transplant. Journal of Heart and Lung Transplantation, 2014; 33: S284.
  • Lachar J, Christopher S, Flattery MP, Shah KB, Tang D, Smallfield MC, Ailes M, Cooke RH, Kasirajan V & Smallfield GB. Gastrointestinal bleeding in patients with ventricular assist devices and total artificial hearts. Poster presentation, DDW, Chicago, May, 2014
  • Kimball P, McDougan F, Flattery M & and Shah K. Sensitization after Heartmate II implantation reduces transplant access. Poster presentation,World Transplant Congress, San Francisco,July 26-31, 2014

PUBLICATIONS

  • Flattery M Baker K. (1996) Reverse shunting through a patent foramen ovale: Nursing assessment and strategies. Critical Care Nurse, 16(2), 58-64.
  • Suddaby EC, Flattery MP, Luna M. (1997) Stress and coping among parents of children awaiting cardiac transplantation. Journal of Transplant Coordination, 7, 36-40.
  • Flattery MP. (1998) Incidence and treatment of cancer in transplant recipients. Journal of Transplant Coordination, 8, 105-10.
  • Kimball P, Verbeke S, Flattery M, Rhodes C, Tolman D. (2000) Influenza vaccination does not promote cellular or humoral activation among heart transplant recipients. Transplantation, 69, 2449-51.
  • Salyer JJ, Flattery MP Joyner PL. (2003) Lifestyle and quality of life in long-term cardiac transplant recipients. Journal of Heart and Lung Transplantation.22, 309-321.
  • Kundar RN, Flattery MP Hess ML. (2003)Homocysteine/Coronary Atherosclerosis and Cardiac Transplantation: A Case Control Study. Frontiers in Cardiovascular Health. 171-6.
  • Flattery MP Baker KM. (2004) Evidence for racial disparity in cardiac transplantation. Journal of Cultural Diversity. 11, 25-30.
  • Flattery MP, Pinson JM, Savage L & Salyer J. (2005) Living with pulmonary artery hypertension: patients’ experiences.Heart & Lung: The Journal of Acute and Critical Care. 34, 99-107.
  • Higgins R, Kirklin JK, Brown RN, Rayburn B, Wagoner L, Oren R, Miller L, Flattery M Bourge RC. (2005). To induce or not to induce: Do patients at greatest risk of fatal rejection benefit from cytolytic induction therapy. Journal of Heart and Lung Transplantation.24,392-400.
  • Flattery MPGravatt LA. (2005). COX-2 inhibitors and cardiovascular risk. Progress in Cardiovascular Nursing.20, 123-5.
  • Baker KM & Flattery MP. (2006) Heparin-induced thrombocytopenia and cardiovascular patients: Recognition and treatment. Progress in Cardiovascular Nursing. 21,47-51.
  • Okum EJ, Perez-Tamayo RA, Higgins RSD, Kasirajan V,Flattery MCrowley S. (2006) Administration of rabbit anti-thymocyte globulin during cardiopulmonary bypass: a novel approach to the highly sensitized cardiac transplant patient. Journal of Heart and Lung Transplantation. 25,608-10.
  • Flattery MP, Salyer J, Maltby MC, Joyner PL & Elswick RK. (2006) Lifestyle and health status differ over time in long-term cardiac transplant recipients.Progress in Transplantation. 16, 232-8.
  • Wong B & Flattery MP. (2006)The use of digoxin in the treatment of chronic heart failure. Progress in Cardiovascular Nursing. 21, 158-61.
  • Kimball P, Flattery M & Kasirajan V. (2006) T-cell response to staphylococcal enterotoxin B is reduced among heart failure patients on ventricular device support. Transplantation Proceedings.38, 3695-6.
  • Flattery MP & Sica DA. (2007) Angiotensin converting enzyme-related angioedema: recognition and treatment. Progress in Cardiovascular Nursing. 22, 47-51.
  • Cahoon W, Flattery MP & Hess ML. (2007) Amiodorone: Development, clinical indications and safety. Progress in Cardiovascular Nursing.22, 173-6.
  • Salyer J, Flattery M, Joyner P, Friend J & Elswick RK. (2007)Community-based weight management in long-term cardiac transplant recipients: results of a pilot study. Progress in Transplantation. 17, 315-23.
  • Cahoon W & Flattery MP. (2008) ACC/AHA Non-ST-Elevation Myocardial Infarction Guideline Revision 2007: Implications for Nursing Practice. Progress in Cardiovascular Nursing. 23, 53-6.
  • Kimball PM, Flattery M, McDougan F & Kasirajan V. (2008) Cellular immunity impaired among patients on left ventricular assist device for 6 months. Annals Thoracic Surgery. 85:1656-61.
  • Flattery MP. (2008) Herbal Therapies and Cardiac Side Effects. Progress in Cardiovascular Nursing.23, 187-90.
  • Bean M, Gibson D, Flattery M, Duncan A & Hess M. (2009). Psychological factors, quality of life, and psychological distress: ethnic differences in patients with heart failure. Progress in Cardiovascular Nursing, 24, 131-40.
  • Baker K, Flattery M, Salyer J, Haugh KH & Maltby M. (2010) Caregiving for patients requiring left ventricular assist device support. Heart & Lung: The Journal of Acute and Critical Care, 39, 196-200.
  • Shah KB, Tang DG, Cooke RH, Harton S, Flattery M, Katlaps GJ, Kasirajan V & Hess ML. (2011) Implantable mechanical circulatory support: Demystifying patients with ventricular assist devices and artificial hearts. Clinical Cardiology, 34, 147-52.
  • Kohli HS, Canada J, Arena RA, Tang DG, Peberdy MA, Harton S, Flattery M, Katlaps GJ, Hess ML, Kasirajan V & Shah KB. (2011) Exercise blood pressure response during assisted circulatory support: Comparison of the total artificial heart with a left ventricular assist device during rehabilitation.Journal of Heart and Lung Transplantation,30:1207-13.
  • Mankad AK, Tang DG, Clark WB,Flattery M, Harton S, Katlaps GJ, Stribling WK, Cooke RH, Hess ML, Kasirajan V & Shah KB. (2012) Persistent anemia after implantation of the total artificial heart.Journal of Cardiac Failure,18: 433-8.

Savage LS, Salyer J, Flattery MP, Alburger L, Joyce K, Mann B, Ravindar M, Gonzalez M. (2013). Living with a total artificial heart: patients' perspectives.

Journal of Cardiovascular Nursing. (2014); 29:E1-8.

  • Maltby MC, Flattery MP, Burns B, Salyer J, Weinland S & Shah KB. Psychosocial assessment of candidates and risk classification of patients considered for durable mechanical circulatory support. Journal of Heart and Lung Transplantation, (in press).